{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:04:35Z","timestamp":1780635875890,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jss.2025.08.010","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T09:24:14Z","timestamp":1757755454000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical Characteristics and Survival Outcomes of Metaplastic Breast Carcinoma Subtypes: A Retrospective Study"],"prefix":"10.1016","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4734-9217","authenticated-orcid":false,"given":"Jazzalyn","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Den","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiy","family":"Golovko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Suzanne","family":"Klimberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2025.08.010_bib1","first-page":"261","article-title":"The burden of rare cancers in the United States","volume":"67","author":"DeSantis","year":"2017","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.jss.2025.08.010_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.clbc.2023.04.004","article-title":"Metaplastic breast cancer: current understanding and future directions","volume":"23","author":"Thomas","year":"2023","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jss.2025.08.010_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002341","article-title":"Metaplastic breast carcinoma versus triple-negative breast cancer: survival and response to treatment","volume":"94","author":"Aydiner","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jss.2025.08.010_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2162-3619-2-31","article-title":"Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies","volume":"2","author":"Schwartz","year":"2013","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jss.2025.08.010_bib5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1159\/000525324","article-title":"Metaplastic breast cancer: mesenchymal subtype has worse survival outcomes","volume":"17","author":"\u00d6zkurt","year":"2022","journal-title":"Breast Care"},{"key":"10.1016\/j.jss.2025.08.010_bib6","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1245\/s10434-020-09430-5","article-title":"Survival outcomes for metaplastic breast cancer differ by histologic subtype","volume":"28","author":"Tadros","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2025.08.010_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41523-021-00302-z","article-title":"Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma","volume":"7","author":"Wong","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.jss.2025.08.010_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1158\/1078-0432.CCR-21-2182","article-title":"A multicenter phase II trial of ipilimumab and nivolumab in unresectable or metastatic metaplastic breast cancer: cohort 36 of dual Anti-CTLA-4 and Anti-PD-1 blockade in rare tumors (DART, SWOG S1609)","volume":"28","author":"Adams","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2025.08.010_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1159\/000515510","article-title":"Durable response to PD1 inhibitor pembrolizumab in a metastatic, metaplastic breast cancer","volume":"14","author":"Gorshein","year":"2021","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.jss.2025.08.010_bib10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.12659\/AJCR.918770","article-title":"Complete response of chemo-refractory metastatic metaplastic breast cancer to paclitaxel-immunotherapy combination","volume":"20","author":"Al Sayed","year":"2019","journal-title":"Am J Case Rep"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480425005372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480425005372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:42:39Z","timestamp":1780634559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480425005372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":10,"alternative-id":["S0022480425005372"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2025.08.010","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics and Survival Outcomes of Metaplastic Breast Carcinoma Subtypes: A Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2025.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}